| Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention R Buettner, LB Mora, R Jove Clinical cancer research 8 (4), 945-954, 2002 | 1476 | 2002 |
| Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells LB Mora, R Buettner, J Seigne, J Diaz, N Ahmad, R Garcia, T Bowman, ... Cancer research 62 (22), 6659-6666, 2002 | 735 | 2002 |
| Stat3 regulates genes common to both wound healing and cancer DJ Dauer, B Ferraro, L Song, B Yu, L Mora, R Buettner, S Enkemann, ... Oncogene 24 (21), 3397-3408, 2005 | 461 | 2005 |
| Expression of insulin-like growth factor-1 receptor in human colorectal cancer A Hakam, TJ Yeatman, L Lu, L Mora, G Marcet, SV Nicosia, RC Karl, ... Human pathology 30 (10), 1128-1133, 1999 | 309 | 1999 |
| Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity J Turkson, S Zhang, J Palmer, H Kay, J Stanko, LB Mora, S Sebti, H Yu, ... Molecular cancer therapeutics 3 (12), 1533-1542, 2004 | 259 | 2004 |
| A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells J Turkson, S Zhang, LB Mora, A Burns, S Sebti, R Jove Journal of Biological Chemistry 280 (38), 32979-32988, 2005 | 229 | 2005 |
| Inhibition of Bcr–Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells M Huang, JF Dorsey, PK Epling-Burnette, R Nimmanapalli, TH Landowski, ... Oncogene 21 (57), 8804-8816, 2002 | 187 | 2002 |
| Deregulated expression of LRBA facilitates cancer cell growth JW Wang, JJ Gamsby, SL Highfill, LB Mora, GC Bloom, TJ Yeatman, ... Oncogene 23 (23), 4089-4097, 2004 | 162 | 2004 |
| Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone L Burdelya, R Catlett-Falcone, A Levitzki, F Cheng, LB Mora, E Sotomayor, ... Molecular cancer therapeutics 1 (11), 893-899, 2002 | 72 | 2002 |
| The Mainz classification of renal cell tumors JI Diaz, LB Mora, A Hakam Cancer Control 6 (6), 571-579, 1999 | 56 | 1999 |
| Significance of Fas and retinoblastoma protein expression during the progression of Barrett’s metaplasia to adenocarcinoma D Coppola, RH Schreiber, L Mora, W Dalton, RC Karl Annals of Surgical Oncology 6, 298-304, 1999 | 55 | 1999 |
| Cyclin D1 expression as a prognostic parameter in papillary carcinoma of the thyroid CA Muro-Cacho, T Holt, D Klotch, L Mora, S Livingston, N Futran Otolaryngology—Head and Neck Surgery 120 (2), 200-207, 1999 | 43 | 1999 |
| Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10 JF Torres-Roca, M DeSilvio, LB Mora, LY Khor, E Hammond, N Ahmad, ... Urology 69 (3), 505-509, 2007 | 40 | 2007 |
| Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients LB Mora, SV Nicosia, JM Pow-Sang, NK Ku, JI Diaz, J Lockhart, ... The Journal of urology 156 (1), 49-55, 1996 | 39 | 1996 |
| Differential diagnosis of endometrial hyperplasia and carcinoma by computerized image cytometry of cell proliferation, apoptosis and Bcl-2 expression LB Mora, JI Diaz, AB Cantor, SV Nicosia Annals of Clinical & Laboratory Science 29 (4), 308-315, 1999 | 30 | 1999 |
| Stage B Prostate cancer: correlation of DNA ploidy analysis with histological and clinical parameters LB Mora, LC Moscinski, JI Diaz, P Blair, AB Cantor, JM Pow-Sang Cancer Control 6 (6), 587-591, 1999 | 25 | 1999 |
| Arthroscopic retrieval of an unusual foreign body of the knee V Sansone, L Mora, D De Spirito Arthroscopy: The Journal of Arthroscopic & Related Surgery 18 (2), 1-3, 2002 | 22 | 2002 |
| Prostate adenocarcinoma: cellular and molecular abnormalities LB Mora, R Buettner, N Ahmad, Y Bassel, R Jove, JD Seigne Cancer Control 8 (6), 551-561, 2001 | 22 | 2001 |
| Cytometric analysis of Fas and Bcl-2 expression in normal prostatic epithelium and prostate cancer JI Diaz, JM Pow-Sang, LB Mora, JD Seigne, AB Cantor, WS Dalton Urologic Oncology: Seminars and Original Investigations 5 (4), 149-154, 2000 | 20 | 2000 |
| Predictability of PSA failure in prostate cancer by computerized cytometric assessment of tumoral cell proliferation JI Diaz, LB Mora, PF Austin, CA Muro-Cacho, AB Cantor, SV Nicosia, ... Urology 53 (5), 931-938, 1999 | 20 | 1999 |
William KerrProfessor of Microbiology & ImmunologyVerified email at upstate.edu
